Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Carlson

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Biotechnology Healthcare|February 21, 2013
Road To Developing Regulatory Pathway For Biologic Follow-ons Has Many TurnsBob Carlson
Biotechnology Healthcare|February 21, 2013
Task force breaks new ground with breast cancer recommendationsBob Carlson
Biotechnology Healthcare|February 21, 2013
Pooling resources to improve cancer researchBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|December 26, 2012
A truer way to measure value of diagnostic testsBob Carlson
Biotechnology Healthcare|May 19, 2012
In Search of the Perfect Business Model: As personalized medicine moves into the mainstream, makers of diagnostics must face a new economic reality. How to develop a value proposition in a healthcare market that is becoming increasingly elastic?Bob Carlson
Biotechnology Healthcare|May 19, 2012
Saving dollars, preventing disappointmentBob Carlson
Biotechnology Healthcare|April 6, 2012
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|April 6, 2012
A wish list for molecular testsBob Carlson
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Biotechnology Healthcare|February 21, 2013
Road To Developing Regulatory Pathway For Biologic Follow-ons Has Many TurnsBob Carlson
Biotechnology Healthcare|February 21, 2013
Task force breaks new ground with breast cancer recommendationsBob Carlson
Biotechnology Healthcare|February 21, 2013
Pooling resources to improve cancer researchBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|December 26, 2012
A truer way to measure value of diagnostic testsBob Carlson
Biotechnology Healthcare|May 19, 2012
In Search of the Perfect Business Model: As personalized medicine moves into the mainstream, makers of diagnostics must face a new economic reality. How to develop a value proposition in a healthcare market that is becoming increasingly elastic?Bob Carlson
Biotechnology Healthcare|May 19, 2012
Saving dollars, preventing disappointmentBob Carlson
Biotechnology Healthcare|April 6, 2012
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|April 6, 2012
A wish list for molecular testsBob Carlson
Pageof 10